The Role of Cysteine and Serine Proteases in Gastric Carcinogenesis and Their Prognostic Impact in Gastric Cancer

[1]  M. Rugge,et al.  Cysteine and serine proteases in gastric cancer , 1995, Cancer.

[2]  M. Rugge,et al.  Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Interdisciplinary Group on Gastric Epithelial Dysplasia. , 1994, Gastroenterology.

[3]  P. Quax,et al.  Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasis. , 1994, Gastroenterology.

[4]  M. Pignatelli,et al.  Current concepts in metastasis. , 1994, Gut.

[5]  K. Becker,et al.  Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer. , 1994, Cancer research.

[6]  P. Correa,et al.  Phenotypic and genotypic events in gastric carcinogenesis. , 1994, Cancer research.

[7]  M. Rugge,et al.  p53 alteration in gastric precancerous lesions. , 1994, The American journal of pathology.

[8]  S. Brem,et al.  Elevated levels of urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 in malignant human brain tumors. , 1994, Cancer research.

[9]  F. Spyratos,et al.  Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas. , 1994, British Journal of Cancer.

[10]  T. Terada,et al.  Pancreatic trypsinogen and cathepsin B in human pancreatic carcinomas and associated metastatic lesions. , 1994, British Journal of Cancer.

[11]  K. Ishikawa,et al.  Clinical Application of Serum Pepsinogen I and II Levels for Mass Screening to Detect Gastric Cancer , 1993, Japanese journal of cancer research : Gann.

[12]  J. Reilly,et al.  Reduced tissue type plasminogen activator activity of the gastroduodenal mucosa in peptic ulcer disease. , 1993, Gut.

[13]  F. Farinati,et al.  Aspartic proteinases and gastrin in the diagnosis of gastric cancer and gastric precancerous changes , 1993 .

[14]  W. Clarkston,et al.  The use of GoLYTELY and Dulcolax in combination in outpatient colonoscopy. , 1993, Journal of clinical gastroenterology.

[15]  M. Rugge,et al.  Early and advanced gastric cancer in the follow-up of moderate and severe gastric dysplasia patients. A prospective study. I.G.G.E.D.--Interdisciplinary Group on Gastric Epithelial Dysplasia. , 1993, Endoscopy.

[16]  A. Aasen,et al.  Location of plasminogen activator (PA) and PA inhibitor in human colorectal adenocarcinomas , 1993, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[17]  H. Verspaget,et al.  Plasminogen activators in normal tissue and carcinomas of the human oesophagus and stomach. , 1993, Gut.

[18]  T. Okuda,et al.  Significance of serum markers pepsinogen I and II for chronic atrophic gastritis, peptic ulcer, and gastric cancer. , 1993, Journal of clinical gastroenterology.

[19]  P. Correa,et al.  Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. , 1992, Cancer research.

[20]  I. Hart,et al.  Biology of tumour metastasis , 1992, The Lancet.

[21]  M. Duffy,et al.  Type‐1 plasminogen activator inhibitor in human breast carcinomas , 1992, International journal of cancer.

[22]  H. Kawanishi,et al.  Plasminogen activators in human gastric cancers: Correlation with DNA ploidy and immunohistochemical staining , 2007, International journal of cancer.

[23]  P. Quax,et al.  Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasia. Implications of urokinase in colorectal carcinogenesis. , 1991, Gastroenterology.

[24]  M. Rugge,et al.  Gastric epithelial dysplasia: a prospective multicenter follow-up study from the Interdisciplinary Group on Gastric Epithelial Dysplasia. , 1991, Human pathology.

[25]  K. Sheahan,et al.  Cysteine endopeptidase activity levels in normal human tissues, colorectal adenomas and carcinomas , 1991, International journal of cancer.

[26]  M. Yasutomi,et al.  Plasminogen activator inhibitor 1 in human carcinoma tissues , 1991, International journal of cancer.

[27]  A. Price.  The Sydney System: Histological division , 1991, Journal of gastroenterology and hepatology.

[28]  M. Rugge,et al.  Epithelial dysplasia in atrophic gastritis. Bioptical follow-up study. , 1991, The Italian journal of gastroenterology.

[29]  D. Nitti,et al.  CA 50 Determination in body fluids: Can we screen patients at risk for gastric cancer? , 1991, International journal of cancer.

[30]  T. Saku,et al.  Cathepsins D and E in normal, metaplastic, dysplastic, and carcinomatous gastric tissue: an immunohistochemical study. , 1990, Gut.

[31]  M F Dixon,et al.  High grade dysplasia of the gastric mucosa: a marker for gastric carcinoma. , 1990, Gut.

[32]  S. Chung,et al.  Protease activities in gastric cancer tissues. , 1990, Clinica chimica acta; international journal of clinical chemistry.

[33]  Bonnie F. Sloane.  Cathepsin B and cystatins: evidence for a role in cancer progression. , 1990, Seminars in cancer biology.

[34]  B. J. Unwin,et al.  The British Society of Gastroenterology early gastric cancer/dysplasia survey: an interim report. , 1990, Gut.

[35]  Y. Yokota,et al.  Purification and properties of cathepsin B from sea urchin eggs , 1990 .

[36]  M. Watanabe,et al.  Cathepsin B and L activities in gastric cancer tissue: correlation with histological findings. , 1989, Biochemical medicine and metabolic biology.

[37]  M. Rugge,et al.  Follow-up in gastric dysplasia patients. , 1989, The American journal of surgical pathology.

[38]  P. Correa,et al.  A human model of gastric carcinogenesis. , 1988, Cancer research.

[39]  Y. Takada,et al.  The urokinase type of plasminogen activator in cancer of digestive tracts. , 1988, Thrombosis research.

[40]  D. Nitti,et al.  CA 19-9 determination in gastric justice: Role in identifying gastric cancer and high risk patients , 1988 .

[41]  P. Correa.  Chronic gastritis: a clinico-pathological classification. , 1988, The American journal of gastroenterology.

[42]  G. Markus.  The relevance of plasminogen activators to neoplastic growth. A review of recent literature. , 1988, Enzyme.

[43]  D. Rifkin,et al.  Cell-associated plasminogen activation: regulation and physiological functions. , 1988, Annual review of cell biology.

[44]  H. Verspaget,et al.  Plasminogen activators and tumor development in the human colon: activity levels in normal mucosa, adenomatous polyps, and adenocarcinomas. , 1987, Cancer research.

[45]  K. Huber,et al.  Pattern of fibrinolytic parameters in patients with gastrointestinal carcinomas , 1987 .

[46]  C. Kluft,et al.  Plasminogen activator inhibitors. , 1987, Blood.

[47]  A. Barrett,et al.  Elastinolytic activity of human cathepsin L. , 1986, The Biochemical journal.

[48]  A. Cuschieri,et al.  Proteinase‐like peptidase activities in malignant and non‐malignant gastric tissue , 1985, The British journal of surgery.

[49]  K. Danø,et al.  Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.

[50]  N. Muñoz,et al.  Gastric dysplasia. Significance and pathologic criteria , 1984, Cancer.

[51]  A. Piccoli,et al.  Carcinoembryonic antigen in gastric juice collected during endoscopy. Value in detecting high‐risk patients and gastric cancer , 1983, Cancer.

[52]  D. Ransohoff,et al.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. , 1983, Human pathology.

[53]  P. Sipponen,et al.  Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma. Comparison with a representative population sample , 1983, Cancer.

[54]  J. Rotter,et al.  Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. , 1982, Gastroenterology.

[55]  L. Sobin,et al.  Precancerous conditions and epithelial dysplasia in the stomach. , 1980, Journal of clinical pathology.

[56]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.